【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Enablex/Emselex
04.1.2 Gelnique
04.1.3 Oxytrol
04.1.4 Botox
04.1.5 Sanctura/ Sanctura XR
04.1.6 Myrbetriq
04.1.7 Vesicare
04.1.8 Detrol/Detrol LA
04.1.9 Toviaz
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Molecule Type
08.1 Biologics
08.2 Small Molecules
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
09.3 Topical
10. Market Segmentation by Class of drugs
10.1 Anti-muscarinic Agent
10.2 Beta-3-Adrenergic Receptor Agonist
11. Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
11.3 Semisolid
11.4 Transdermal
12. Rate of Incidence and Prevalence
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.2.1 Actavis
21.2.2 Allergan
21.2.3 Astellas Pharma
21.2.4 Pfizer
21.3 Other and Future Prominent Vendors
22. Pipeline Portfolio
23. Key Vendor Analysis
23.1 Actavis plc
23.1.1 Key Facts
23.1.2 Business Description
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.2 Allergan Inc.
23.2.1 Key Facts
23.2.2 Business Description
23.2.3 Business Segmentation
23.2.4 Revenue by Business Segmentation
23.2.5 Revenue Comparison 2011-2013
23.2.6 Revenue by Geographical Segmentation
23.2.7 Business Strategy
23.2.8 Key Developments
23.2.9 SWOT Analysis
23.3 Astellas Pharma
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Product Segmentation by Revenue 2012 and 2013
23.3.5 Geographical Segmentation by Revenue 2013
23.3.6 Business Strategy
23.3.7 Recent Developments
23.3.8 SWOT Analysis
23.4 Pfizer
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
24. Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Overactive Bladder Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type 2013
Exhibit 5: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration
Exhibit 6: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration 2013
Exhibit 7: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs
Exhibit 8: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs 2013
Exhibit 9: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form
Exhibit 10: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form 2013
Exhibit 11: Global Overactive Bladder Therapeutics Market by Geographical Segmentation 2013
Exhibit 12: Global Overactive Bladder Therapeutics Market Share Analysis 2013
Exhibit 13: Prescription chart
Exhibit 14: By drugs prescribed (up to 2011)
Exhibit 15: YoY Sales Comparison of Botox 2008-2013 (in US$ million)
Exhibit 16: YoY Sales Comparison of Vesicare 2008-2013 (in US$ million)
Exhibit 17: YoY Sales Comparison of Vesicare in Japan 2008-2013 (in US$ million)
Exhibit 18: YoY Sales Comparison of Vesicare in the Americas 2008-2013 (in US$ million)
Exhibit 19: YoY Sales Comparison of Vesicare in Europe 2008-2013 (in US$ million)
Exhibit 20: YoY Sales Comparison of Vesicare in Asia 2008-2013 (in US$ million)
Exhibit 21: Sales Comparison of Vesicare 2008-2013 (in US$ million)
Exhibit 22: YoY Sales Comparison of Detrol/Detrol LA 2009-2013 (in US$ million)
Exhibit 23: YoY Sales Comparison of Toviaz 2009-2013 (in US$ million)
Exhibit 24: Pipeline Molecules for the Treatment of Overactive Bladder
Exhibit 25: Global Overactive Bladder Therapeutics Market Business Segmentation 2013
Exhibit 26: Global Overactive Bladder Therapeutics Market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 27: Actavis Plc: Sales by Geography (in US$ million)
Exhibit 28: Allergan Inc.: Business Segmentation
Exhibit 29: Allergan Inc.: Revenue by Business Segmentation 2013
Exhibit 30: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
Exhibit 31: Allergan Inc.: Revenue by Geographical Segmentation 2013
Exhibit 32: Astellas Pharma: Product Segmentation 2013
Exhibit 33: Astellas Pharma: Product Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: Astellas Pharma: Geographical Segmentation by Revenue 2013
Exhibit 35: Pfizer: Business Segmentation by Revenue 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：過活動膀胱（OAB）治療薬の世界市場：抗ムスカリン剤、ß3アドレナリン受容体作動薬■ 英文：Global Overactive Bladder Therapeutics Market 2014-2018
■ 発行日：2014年11月5日
■ 調査会社：TechNavio
■ 商品コード：IRTNTR4514
■ 調査対象地域：グローバル
- 加工食品用シールの世界市場予測（～2023年）The food processing seals market is projected to register a CAGR of 3.3% during the forecast period.The food processing seals market size is projected to grow from USD 2.7 billion in 2018 to USD 3.2 billion, by 2023. Growing demand for processed and packaged food and presence of stringent regulations regarding the use of food-grade seals in regions, such as North America, Europe, and South America …
- バイオマーカーの世界市場予測（～2021年）：安全性マーカー、予測マーカー、代替マーカー、薬力学マーカー、予後マーカーThe global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker …
- ハイブリッド太陽電池市場分析：Analyzing Hybrid Solar CellsThe Sun, believed by the mankind to be just a mere centerpiece of the solar system in which we live is in reality not just a unit but an entire symphonic system which was in place much before the first humans ever walked on planet earth. This system which has been the primary energy source for origin of life on earth is in fact very well adequately positioned by nature to fulfill the needs of ener …
- 眼瞼炎(Blepharitis)の治療薬パイプライン動向（2015年上半期版）Blepharitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Blepharitis - Pipeline Review, H1 2015’, provides an overview of the Blepharitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Blepharitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route …
- LED照明の世界市場予測（～2022）：設置種類別、最終用途別、製品種類別（ランプ＆照明器具）、地域別“LED lighting market expected to grow at a high rate between 2016 and 2022” The global LED lighting market is expected to be valued at USD 92.40 billion by 2022 and is expected to witness a shipment of 14.01 billion units by 2022, at a CAGR of 13.66% and 21.23%, respectively, between 2016 and 2022. The increasing consumer demand for energy-efficient lighting systems, reduction in prices of LEDs, a …
- 防弾服・個人防護の世界市場：市場規模、成長要因Summary This report provides readers with a comprehensive analysis of the Body Armor and Personal Protection market through 2014-2024, including highlights of the demand drivers and growth stimulators for Body Armor and Personal Protection. It also provides an insight on the spending pattern and modernization pattern in different regions around the world. Key Findings The global body armor and per …
- Marafiq：発電所及び企業SWTO分析2015Marafiq - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed in …
- Transcatheter Heart Valve Market Outlook, 2013 – Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure VolumesTranscatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes Summary GBI Research’s “Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes” report examines the marke …
- グローバルにおける電力ケーブル市場（2014-2018）About Power Cables A power cable is an insulated strand of wires that is used to transmit electricity at variable voltage levels. Power cables are mainly used in overhead lines, buildings, and underground wiring applications to transmit electricity. Power cables are available in different sizes and shapes according to the requirements of the Telecommunication, Electrical Equipment, Construction, a …
- 民間航空産業におけるヘッドアップディスプレイ（HUD）市場About HUD An HUD is a display indicator that displays the key flight information onto a transparent screen positioned in front of a pilot's line of sight. HUD finds its applications in the automotive and aviation sectors. It helps increase the situational awareness and enhances safety margins in these sectors. The following are the primary components of an HUD: combiner, projector unit, display pa …
- シガレット（タバコ）の世界市場2015-2019About cigarette Cigarette is considered to be one the most popular methods of smoking across the globe. It gained popularity back in 1880s with the introduction of cigarette producing machine and through various wars such as the Crimean War. However, in the modern era cigarettes are available in various sizes, flavors, as well as colors that attracts both smokers and potential smokers. Technavio's …
- ヒトパピローマウイルス感染症パイプライン（グローバル市場分析）Currently there is significant amount of research being undertaken to study the process of HPV infection causing precancerous changes in normal cells. Also, methods to prevent and manage this situation are also being analyzed. A majority of these studies were previously focusing on cervical cells in women. But in recent years, the realm of research has been extended to other tissues also in which …
- Nasopharyngitis (Common Cold)：グローバル臨床試験レビューH2, 2013Nasopharyngitis (Common Cold) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Nasopharyngitis (Common Cold) Global Clinical Trials Review, H2, 2013" provides data on the Nasopharyngitis (Common Cold) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngitis (Common Cold). It includes an overv …
- 世界のメンブレン（膜）市場動向及び予測：精密濾過、逆浸透、限外濾過、ガス分離、透析、ナノ濾過Membranes are one of the most common filtration elements used in commercial and industrial applications. Membrane is a selective barrier that allows the passage of constituents and retains the others. Membrane properties such as durability, reliability, stability, high permeability and selectivity make membranes essential for use in variety of applications. Most of the membranes are used in water …
- 太陽光発電用ハイブリッドインバーターの世界市場About Solar Hybrid InverterSolar hybrid inverters apart from converting direct current to alternate current can also store excess power while working in tandem with batteries. This type of inverters solves the issues related to renewable energy variability and unreliable grid structures. Technavio’s analysts forecast the global solar hybrid inverter market to grow at a CAGR of 9.05% during the per …
